Note: Ingredients listed on restricted chemical lists
EC/CAS
919-857-5/64742-48-9
Name of the chemical
Naphtha (petroleum), hydrotreated heavy
Concentration
≥70
General Information
Version
6.1
Revision date
2022-04-22
Product name
ULTRAFORM 1060
1.2.1 Relevant identified uses
Industrial use,Professional use Industrial/Professional use spec
Manufacturer Name
ROCOL a division of ITW Ltd
Emergency telephone
+44 (0)113 232 2600, 0344 892 0111
Icons in SDS
Company Information
company name
ROCOL a division of ITW Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
customer.service@rocol.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H226, H304, H336
Hazard statements
Code
Statements
H226
Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Hazard pictograms
GHS02 GHS07 GHS08
Signal word
: Danger
Contains
: HYDROCARBONS, C9-C11, N-ALKANES, ISOALKANES, CYCLICS, < 2% AROMATICS
Hazard statements
: H226 - Flammable liquid and vapour. H304 - May be fatal if swallowed and enters airways. H336 - May cause drowsiness or dizziness.
Precautionary statements
: P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P301+P310+P331 - IF SWALLOWED: Immediately call a POISON CENTER or doctor. Do NOT induce vomiting. P303+P361+P353 - IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water . P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P312 - Call a POISON CENTRE or doctor if you feel unwell.
Supplemental label elements
: EUH066 - Repeated exposure may cause skin dryness or cracking.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
